In pathogenic bacteria, enzymatic modification is the most common mechanism of resistance to aminoglycosides (AGs) (1) . At least 27 AG-modifying enzymes (AMEs) have been described, each belonging to one of three classes: acetyltransferase (AAC), nucleotidyltransferase (ANT), or phosphotransferase (APH).
The most reliable method of identifying specific AMEs is the phosphocellulose binding assay (PBA), described in 1971 by Davies et al., which exploits the affinity of the strongly basic AGs for negatively charged media (4) . If a radiolabeled moiety is enzymatically attached to a particular AG, radioactive counts on the paper will be elevated. Enzymes within any of the three major AME classes may be identified, depending upon which drugs are capable of serving as substrates. Although variations in the PBA, such as buffer composition, preparation of cell-free enzyme extracts, and other reaction parameters, have been described (3, 7, 8) , the principle of the assay has not changed, and the test procedure has remained cumbersome and time-consuming. Less cumbersome means of both screening for AMEs and identifying specific enzymes are needed, especially for large collections of organisms under epidemiologic evaluation. Advances toward this end were made in 1978 by Drasar, who proposed the substitution of disposable microtiter plates for individual serologic tubes in which to perform reactions (7), and in 1982 by Shannon and Phillips, who suggested that AMEs can be screened by using only one or two AG substrates rather than the complete battery necessary for subclassifying enzymes (11). These screening methods are possible since the majority of enzymes within a class share common substrates. Gentamicin, tobramycin, or both, for example, are modified by all AACs described to date.
The purpose of our study was to develop a more convenient microdilution plate PBA for both screening for AMEs and subclassifying enzymes.
MATERIALS AND METHODS
Organisms. Five strains of Pseudomonas aeruginosa used as AME-positive controls were supplied by the Mechanisms * Corresponding author.
of Resistance Service, Bristol Laboratories, Syracuse, N.Y.
I
Also tested were 27 bacterial isolates (see Table 3 ) which I represented five gram-negative species (three genera) and three Staphylococcus species. These isolates were obtained from hospitals and were resistant to at least one AG.
Cell-free lysates of gram-negative bacilli were prepared as follows. Brain heart infusion broth (200 ml in a 500-ml flask) was inoculated with 20 ml of an overnight broth culture and incubated with shaking at 35°C until the late exponential growth phase was reached (usually 4 to 5 h). Cells were harvested by centrifugation, washed twice in 10 ml of cold 0.01 M Tris-0.03 M NaCl (pH 7.8), and suspended in 6 Enzyme assays. Microdilution plate assays for AMEs were performed as described in Table 1 . Isotopes, followed by lysates, were dispensed at the time of the assay into microdilution plates containing substrates. Spotting of reaction mixtures required elevating the phosphocellulose (we used straight pins), using only four equally spaced tips on the multichannel micropipette, and altering the numbering on the paper to correlate with microdilution wells (e.g., wells 1, 4, 7, and 10 on the top one-third of the paper, wells 2, 5, 8, and 11 on the middle one-third, and wells 3, 6, 9, and 12 on the bottom one-third). Conventional AME assays were also performed as described in Table 1 , with the following substitutions. Borosilicate glass tubes (10 by 75 mm), rather than microdilution plates, were used for the reactions. All the components, including the substrates, were dispensed on the day of the assay by using a single-channel micropipette (Gilson Pipetman; Rainin Instrument Co., Woburn, Mass.). Reaction mixtures were spotted individually onto pieces of phosphocellulose (numbered and cut to approximately 1 cm2 before the assay).
Screening assays were performed by the microplate procedure as described in Table 1 except that fewer substrates were tested for each class. Each cell-free lysate was evaluated in a single row (12 wells) of a microplate which contained isotopes, water controls, and the substrates necessary for identifying AMEs to the class level (Table 2) .
For all procedures, a substrate was regarded to be modi- CIA, gentamicin C subfractions; K, kanamycin; LIV, lividomycin; N, neomycin; NET, netilmicin; PAR, paromomycin; SIS, sisomicin; SPT, spectinomycin; S, streptomycin; and TM, tobramycin. For screening assays, H20, GM, and TM were used for AAC, H20, K, N, SPT, and S were used for APH, and H20, K, S, and SPT were used for ANT.
fied if radioactive counts were greater than or equal to five times those of water controls (no AG). Subclassification of enzymes was done by using previously described interpretive tables (1, 3, 6, 11 3"
(methicillin imately equal to those obtained from conventional assays when expressed as multiples of background counts (water controls).
Microplate screening was performed blindly by using lysates assigned a cryptic number to avoid the identification of isolates. AMEs were correctly identified (to the class level) by this assay when the 32 isolates were tested (Table 3) .
A cost comparison for microplate and conventional assays is shown in Table 4 . Costs of materials and reagents were obtained from 1985 commercial retail catalogs and in some instances required averaging, owing to variations in prices among suppliers and units of issue. The performance of 10 APH assays by the microplate, as opposed to the conventional, method cost $14.94 less. While the costs of materials and reagents were slightly higher, the performance of microplate assays required substantially less time, with an estimated labor cost savings of $18.29. Two steps in which the greatest time savings were realized included predispensing of substrates and spotting of reaction mixtures, both of which were facilitated by a multichannel micropipette. Once substrate stocks were prepared, 50 or more plates could be prepared in 15 min or less.
DISCUSSION
The convenient identification of mechanisms of resistance is becoming an important component in investigating outbreaks of drug-resistant organisms. Examples of this technology are the chromogenic cephalosporin test for 13-lactamase (9) and, more recently, nucleic acid probes specific for genes encoding resistance mechanisms (2, 10, 12) . The modified PBA may prove especially useful, since laboratories involved in epidemiologic studies of AG resistance may screen organisms for the presence of AMEs in microdilution plates. Predispensing of substrates and multichannel pipetting further streamline the performance of the assay without sacrificing sensitivity or accuracy. Unlike 1-lactamases, which may be detected without extraction due to secretion or spontaneous autolysis, detection of AMEs continues to require more rigorous lysis procedures. Although not evaluated in the present study, this phase of the assay may also be facilitated, for example, through the use of "mini-preps" which may be obtained from colony suspensions but which nonetheless still require lysis techniques such as osmotic shock or sonication. Another possible variation is that substrate batteries may be altered from those described in this study. These changes are most often related to the availability of various AGs and to the extent of substrate profiling required. The addition of apramycin, for example, may be needed for more in-depth characterization of enzymes that acetylate carbon-3 hydroxyl moieties (5) . Screening plates may also be altered so that, in a single microdilution plate, more isolates may be tested against fewer substrates. By using three substrates and one water control in a typical ANT screen, for example, one may evaluate as many as 24 isolates (three different lysates in each of eight rows) in a single plate, but for this class only.
The costs of performing AME assays, of importance primarily within laboratories in which they are routinely performed, would be expected to decrease as more assays are performed, owing to improvements in technical skills and decreases in costs of materials when purchased in bulk quantities. Although cost analyses of AAC and ANT assays were not performed in this study, it can be assumed that savings would approximate those observed for the APH assay.
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